IN2015DN01414A - - Google Patents
Info
- Publication number
- IN2015DN01414A IN2015DN01414A IN1414DEN2015A IN2015DN01414A IN 2015DN01414 A IN2015DN01414 A IN 2015DN01414A IN 1414DEN2015 A IN1414DEN2015 A IN 1414DEN2015A IN 2015DN01414 A IN2015DN01414 A IN 2015DN01414A
- Authority
- IN
- India
- Prior art keywords
- present
- dabigatran etexilate
- isolation
- require
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1414DEN2015 IN2015DN01414A (h) | 2012-08-31 | 2013-09-02 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN2712DE2012 | 2012-08-31 | ||
| IN1414DEN2015 IN2015DN01414A (h) | 2012-08-31 | 2013-09-02 | |
| PCT/IB2013/058232 WO2014033693A1 (en) | 2012-08-31 | 2013-09-02 | Process for the preparation of crystalline form i of methanesulfonate salt of dabigatran etexilate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2015DN01414A true IN2015DN01414A (h) | 2015-07-03 |
Family
ID=49301574
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN1414DEN2015 IN2015DN01414A (h) | 2012-08-31 | 2013-09-02 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US9150542B2 (h) |
| EP (1) | EP2890692A1 (h) |
| CA (1) | CA2881947A1 (h) |
| IN (1) | IN2015DN01414A (h) |
| WO (1) | WO2014033693A1 (h) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016020471A1 (en) * | 2014-08-07 | 2016-02-11 | Boehringer Ingelheim International Gmbh | Method for producing dabigatran etexilate methanesulphonate |
| CN104725360A (zh) * | 2015-04-09 | 2015-06-24 | 重庆东得医药科技有限公司 | 一种甲磺酸达比加群酯ⅰ晶型的制备方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6087380A (en) | 1949-11-24 | 2000-07-11 | Boehringer Ingelheim Pharma Kg | Disubstituted bicyclic heterocycles, the preparations and the use thereof as pharmaceutical compositions |
| DE10339862A1 (de) | 2003-08-29 | 2005-03-24 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | 3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)- phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsäure-ethylester-Methansulfonat und dessen Verwendung als Arzneimittel |
| DE102005025728A1 (de) | 2005-06-04 | 2006-12-07 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Polymorphe von 3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-Propionsäure-ethylester |
| DE102005061624A1 (de) * | 2005-12-21 | 2007-06-28 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verbessertes Verfahren zur Herstellung von Salzen von 4-(Benzimidazolylmethylamino)-Benzamidinen |
| DE102005061623A1 (de) * | 2005-12-21 | 2007-06-28 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verbessertes Verfahren zur Herstellung von 4-(Benzimidazolylmethylamino)-Benzamidinen und deren Salzen |
| DE102006054005A1 (de) | 2006-11-16 | 2008-05-21 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Polymorphe von 3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsäure-ethylester |
| CA2792273A1 (en) | 2010-03-08 | 2011-09-15 | Ratiopharm Gmbh | Dabigatran etexilate-containing pharmaceutical composition |
| WO2012027543A1 (en) | 2010-08-25 | 2012-03-01 | Teva Pharmaceuticals Usa, Inc. | Solid state forms of dabigatran etexilate, dabigatran etexilate mesylate and processes for preparation thereof |
| WO2012077136A2 (en) | 2010-12-06 | 2012-06-14 | Msn Laboratories Limited | Process for the preparation of benzimidazole derivatives and its salts |
-
2013
- 2013-09-02 WO PCT/IB2013/058232 patent/WO2014033693A1/en active Application Filing
- 2013-09-02 US US14/420,249 patent/US9150542B2/en not_active Expired - Fee Related
- 2013-09-02 IN IN1414DEN2015 patent/IN2015DN01414A/en unknown
- 2013-09-02 EP EP13771630.4A patent/EP2890692A1/en not_active Withdrawn
- 2013-09-02 CA CA2881947A patent/CA2881947A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US9150542B2 (en) | 2015-10-06 |
| WO2014033693A1 (en) | 2014-03-06 |
| EP2890692A1 (en) | 2015-07-08 |
| CA2881947A1 (en) | 2014-03-06 |
| US20150197504A1 (en) | 2015-07-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12016500169A1 (en) | Polymorph of syk inhibitors | |
| MX361653B (es) | Procedimiento para la preparación de derivados del ácido biliar. | |
| IL227648A0 (en) | Process for preparing 4-amino-5-fluoro-3-halo-6-(converted) picolinates | |
| IL227646A0 (en) | Process for preparing 4-amino-3-chloro-5-fluoro-6-(converted) picolinates | |
| IL227647A0 (en) | Process for preparing 4-amino-5-fluoro-3-halo-6- (converted) picolinates | |
| WO2013111163A3 (en) | Process for the preparation of dabigatran etexilate mesylate and polymorphs of intermediates thereof | |
| IL227645B (en) | Process for preparing 4-amino-3-chloro-5-fluoro-6-(converted) picolinates | |
| EP2758387A4 (en) | Pyridine compounds as kinase inhibitors | |
| IN2014DN06964A (h) | ||
| IN2015DN02616A (h) | ||
| IN2013MU03070A (h) | ||
| WO2012140490A3 (en) | Processes for preparing pitavastatin calcium | |
| IN2014DN09451A (h) | ||
| MX2016012485A (es) | Proceso para preparar 3-(3-(4-(1-aminociclobutil)fenil)-5-fenil-3h -imidazo[4,5-b]piridin-2-il)piridin-2-amina. | |
| IN2015DN02601A (h) | ||
| MX363944B (es) | Método de preparación de los compuestos de ceramidas de alfa-galactosilo. | |
| IN2015DN01414A (h) | ||
| WO2013072938A3 (en) | Process for the preparation of roflumilast | |
| IN2013MU04056A (h) | ||
| IL239228A0 (en) | Improved process for the preparation of n-cyano-s-[1-(pyridine-3-yl)ethyl]-s-methylsulfylamines | |
| WO2014170909A3 (en) | Process for pomalidomide | |
| WO2014041558A3 (en) | Process for preparation of crystalline etoricoxib | |
| MX2014012822A (es) | Proceso para elaborar derivados de naftiridina. | |
| IN2013MU01219A (h) | ||
| WO2014020546A3 (en) | Crystalline forms of dabigatran etexilate and process for their preparation |